Morag Griffin

2.0k total citations · 1 hit paper
75 papers, 761 citations indexed

About

Morag Griffin is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, Morag Griffin has authored 75 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 37 papers in Genetics and 34 papers in Hematology. Recurrent topics in Morag Griffin's work include Complement system in diseases (64 papers), Blood groups and transfusion (26 papers) and Renal Diseases and Glomerulopathies (23 papers). Morag Griffin is often cited by papers focused on Complement system in diseases (64 papers), Blood groups and transfusion (26 papers) and Renal Diseases and Glomerulopathies (23 papers). Morag Griffin collaborates with scholars based in United Kingdom, United States and France. Morag Griffin's co-authors include Talha Munir, Peter Hillmen, Jeff Szer, Alexander Röth, Jens Panse, Kensuke Usuki, Ilene C. Weitz, Antonio M. Risitano, Temitayo Ajayi and Britta Höchsmann and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Morag Griffin

61 papers receiving 748 citations

Hit Papers

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal H... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    2021 249 citations Peter Hillmen, Jeff Szer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morag Griffin United Kingdom 14 630 368 311 269 92 75 761
Claire Hall United Kingdom 6 575 0.9× 328 0.9× 296 1.0× 201 0.7× 98 1.1× 6 692
Caroline Piatek United States 11 334 0.5× 203 0.6× 247 0.8× 193 0.7× 70 0.8× 40 623
Camilla Frieri Italy 9 259 0.4× 148 0.4× 174 0.6× 112 0.4× 50 0.5× 18 402
Francesca Gaia Rossi Italy 12 241 0.4× 124 0.3× 180 0.6× 140 0.5× 42 0.5× 32 615
Helen Yarranton United Kingdom 7 354 0.6× 175 0.5× 363 1.2× 126 0.5× 7 0.1× 12 583
Shintaro Shiobara Japan 18 640 1.0× 70 0.2× 788 2.5× 113 0.4× 15 0.2× 55 1.1k
Norihiro Iwamoto Japan 12 291 0.5× 138 0.4× 141 0.5× 74 0.3× 72 0.8× 26 463
Manuela Colucci Italy 16 267 0.4× 490 1.3× 142 0.5× 170 0.6× 3 0.0× 37 763
B. Sean Carey United Kingdom 9 278 0.4× 51 0.1× 39 0.1× 133 0.5× 8 0.1× 20 507
Kazutoshi Kaketani Japan 7 197 0.3× 101 0.3× 133 0.4× 59 0.2× 5 0.1× 15 325

Countries citing papers authored by Morag Griffin

Since Specialization
Citations

This map shows the geographic impact of Morag Griffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morag Griffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morag Griffin more than expected).

Fields of papers citing papers by Morag Griffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morag Griffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morag Griffin. The network helps show where Morag Griffin may publish in the future.

Co-authorship network of co-authors of Morag Griffin

This figure shows the co-authorship network connecting the top 25 collaborators of Morag Griffin. A scholar is included among the top collaborators of Morag Griffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morag Griffin. Morag Griffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manning, James E., et al.. (2025). Paroxysmal nocturnal haemoglobinuria in pregnancy–a systematic review with meta analysis. Annals of Hematology. 104(4). 2517–2525.
2.
Kulasekararaj, Austin, Robert A. Brodsky, Hubert Schrezenmeier, et al.. (2025). Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria. Annals of Hematology. 104(1). 81–94. 2 indexed citations
3.
Griffin, Morag, Richard J. Kelly, Jens Panse, et al.. (2024). Management of acute breakthrough hemolysis with intensive pegcetacoplan dosing in patients with PNH. Blood Advances. 8(7). 1776–1786. 19 indexed citations
4.
Griffin, Morag, Richard Kelly, Petra Muus, et al.. (2024). Real‐world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria. American Journal of Hematology. 99(5). 816–823. 17 indexed citations
5.
Piatek, Caroline, Jong Wook Lee, Morag Griffin, et al.. (2024). Danicopan As Add-on Therapy to Ravulizumab or Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Long-Term Patient-Reported Outcomes from the Phase 3 ALPHA Trial. Blood. 144(Supplement 1). 2692–2692. 1 indexed citations
6.
7.
Thomas, Stephen H., et al.. (2024). Mapping aplastic anaemia hospital activity in England. SHILAP Revista de lepidopterología. 5(2). 414–417. 1 indexed citations
8.
Kulasekararaj, Austin, Jamie Cavenagh, Inderjeet Dokal, et al.. (2024). Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline. British Journal of Haematology. 204(3). 784–804. 35 indexed citations
9.
Patriquin, Christopher J., Andrija Bogdanović, Morag Griffin, et al.. (2024). Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study. Advances in Therapy. 41(5). 2050–2069. 8 indexed citations
10.
11.
Kelly, Richard, Matthew T. Holt, Jennifer Vidler, et al.. (2023). Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria. Blood. 143(12). 1157–1166. 21 indexed citations
12.
Jang, Jun‐Ho, Raymond Wong, Jonathan Weyne, et al.. (2023). P775: LONG-TERM EFFICACY AND SAFETY OF POZELIMAB MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. HemaSphere. 7(S3). e4357016–e4357016. 2 indexed citations
13.
Latour, Régis Peffault de, Jeff Szer, Ilene C. Weitz, et al.. (2022). Pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal haemoglobinuria (PEGASUS): 48-week follow-up of a randomised, open-label, phase 3, active-comparator, controlled trial. The Lancet Haematology. 9(9). e648–e659. 43 indexed citations
14.
Griffin, Morag, et al.. (2022). Experience of compassionate-use pegcetacoplan for paroxysmal nocturnal hemoglobinuria. Blood. 141(1). 116–120. 9 indexed citations
15.
Hill, Anita, Régis Peffault de Latour, Austin Kulasekararaj, et al.. (2022). Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis. Acta Haematologica. 146(1). 1–14. 7 indexed citations
16.
Avenoso, Daniele, Judith Marsh, Victoria Potter, et al.. (2021). SARS-CoV-2 infection in aplastic anemia. Haematologica. 107(2). 541–543. 13 indexed citations
17.
18.
Griffin, Morag, Talha Munir, Peter Hillmen, et al.. (2017). Thrombosis in Non-Hemolytic Paroxysmal Nocturnal Haemogloinuria. Blood. 130. 1175–1175. 1 indexed citations
19.
Richards, Stephen J., Talha Munir, Morag Griffin, et al.. (2017). Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome. Blood. 130. 3471–3471. 21 indexed citations
20.
Hill, Anita, Miles A. Nunn, Tadeusz Robak, et al.. (2017). Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial. Blood. 130. 4747–4747. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Hall Breakdown of academic impact, for papers by Caroline Piatek Breakdown of academic impact, for papers by Camilla Frieri Breakdown of academic impact, for papers by Francesca Gaia Rossi Breakdown of academic impact, for papers by Helen Yarranton Breakdown of academic impact, for papers by Shintaro Shiobara Breakdown of academic impact, for papers by Norihiro Iwamoto Breakdown of academic impact, for papers by Manuela Colucci Breakdown of academic impact, for papers by B. Sean Carey Breakdown of academic impact, for papers by Kazutoshi Kaketani
Rankless by CCL
2026